SilkTech Biopharmaceuticals


SilkTech Biopharmaceuticals develops silk-based anti-inflammatory therapies. Their lead indication is Dry Eye Disease, an inflammatory-based chronic condition.

Industries

Employees

11-50

Links


Org chart

Brian Lawrence
Chief Executive Officer
Collapse
David Infanger
VP, Research & Development

Board & advisors

Brian Levy
Executive Chairman
Alex Soltani
Board Member
Bill Mower
Board Member
Emmett Cunningham
Board Member
Paul M. Karpecki
Board Member


Offices